Published in Clin Lymphoma Myeloma on October 01, 2008
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma. Leukemia (2009) 2.50
Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance. Blood Cancer J (2013) 1.17
Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry. Haematologica (2012) 1.04
Immunological dysregulation in multiple myeloma microenvironment. Biomed Res Int (2014) 0.98
Cellular mechanisms of multiple myeloma bone disease. Clin Dev Immunol (2013) 0.96
Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells. Gene Ther (2011) 0.95
Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma. Am J Hematol (2016) 0.84
Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut. Am J Hematol (2010) 0.81
Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma. Oncoimmunology (2012) 0.79
Modernising medical careers, medical training application service, and the postgraduate medical education and training board: time for the emperors to don their clothes. Lancet (2007) 3.12
Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood (2003) 2.31
Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache (2005) 2.16
Salvage second hematopoietic cell transplantation in myeloma. Biol Blood Marrow Transplant (2013) 1.80
Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature. Clin Experiment Ophthalmol (2013) 1.70
CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis. Blood (2012) 1.65
Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma. Leuk Lymphoma (2014) 1.60
Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure. Biol Blood Marrow Transplant (2011) 1.57
Presence of Hoechst low side populations in multiple myeloma. Leuk Lymphoma (2008) 1.51
Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia. Biol Blood Marrow Transplant (2006) 1.49
Cultural similarities and differences in medical professionalism: a multi-region study. Med Educ (2012) 1.44
A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol (2002) 1.39
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1. Haematologica (2011) 1.31
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma. Biol Blood Marrow Transplant (2009) 1.28
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity? Blood (2012) 1.23
The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax (2012) 1.22
Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood (2009) 1.21
Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. Biol Blood Marrow Transplant (2009) 1.14
Spinal leptomeningeal lymphoma presenting as pseudotumor syndrome. J Neuroophthalmol (2013) 1.13
Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg (2003) 1.09
Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors. Haematologica (2013) 1.07
Lower branch coherent states in shear flows: transition and control. Phys Rev Lett (2007) 1.07
Comment on "Profiling oil sands mixtures from industrial developments and natural groundwaters for source identification". Environ Sci Technol (2014) 1.06
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood (2002) 1.03
Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma. Leuk Lymphoma (2009) 1.00
Either interleukin-12 or interferon-gamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma. Br J Haematol (2004) 1.00
Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. Biol Blood Marrow Transplant (2004) 1.00
The impact of immigration on child health: experimental evidence from a migration lottery program. Econ Inq (2012) 0.99
Medical training in the UK: sleepwalking to disaster. Lancet (2007) 0.99
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant (2014) 0.95
Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma. Biol Blood Marrow Transplant (2013) 0.93
Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant (2013) 0.92
Migration and mental health: Evidence from a natural experiment. J Health Econ (2009) 0.92
Training in oral disease, diagnosis and treatment for medical students and doctors in the United Kingdom. Br J Oral Maxillofac Surg (2005) 0.92
Frequent genetic differences between matched primary and metastatic breast cancer provide an approach to identification of biomarkers for disease progression. Eur J Hum Genet (2010) 0.92
Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study. Clin Lymphoma Myeloma Leuk (2010) 0.90
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant (2011) 0.90
Interferon-alpha in the treatment of multiple myeloma. Curr Drug Targets (2011) 0.90
Preliminary benchmarking of appropriate sanctions for lapses in undergraduate professionalism in the health professions. Med Teach (2011) 0.87
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies. Biol Blood Marrow Transplant (2011) 0.87
Susceptibility of heat shock protein 70.1-deficient C57BL/6 J, wild-type C57BL/6 J and A/J mice to Trypanosoma congolense infection. Parasitol Res (2003) 0.87
Comparison of twin and autologous transplants for multiple myeloma. Biol Blood Marrow Transplant (2008) 0.87
Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation? Am J Hematol (2006) 0.86
Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR. Biol Blood Marrow Transplant (2011) 0.85
Phenotyping primitive plasma cells. Br J Haematol (2002) 0.85
A comprehensive genetic analysis of candidate genes regulating response to Trypanosoma congolense infection in mice. PLoS Negl Trop Dis (2010) 0.85
Genetic and expression analysis of cattle identifies candidate genes in pathways responding to Trypanosoma congolense infection. Proc Natl Acad Sci U S A (2011) 0.85
Clinical chemistry of congenic mice with quantitative trait loci for predicted responses to Trypanosoma congolense infection. Infect Immun (2009) 0.84
Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state. Leuk Lymphoma (2013) 0.84
The use of thalidomide in myeloma therapy as an effective anticancer drug. Curr Cancer Drug Targets (2006) 0.84
Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation. Biol Blood Marrow Transplant (2008) 0.83
Expression of trypanotolerance in N'Dama x Boran crosses under field challenge in relation to N'Dama genome content. BMC Proc (2011) 0.83
Genotype and expression analysis of two inbred mouse strains and two derived congenic strains suggest that most gene expression is trans regulated and sensitive to genetic background. BMC Genomics (2010) 0.83
Factors influencing the abundance of the side population in a human myeloma cell line. Bone Marrow Res (2011) 0.83
The management of dental patients taking new generation oral anticoagulants. Prim Dent J (2014) 0.83
Recombinant tumor necrosis factor alpha does not inhibit the growth of African trypanosomes in axenic cultures. Infect Immun (2002) 0.82
Fasciculations and cramps: how benign? Report of four cases progressing to ALS. J Neurol (2010) 0.82
Clonal cytotoxic T cells in myeloma. Leuk Lymphoma (2003) 0.80
Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement. Br J Haematol (2013) 0.80
Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant (2008) 0.79
Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol. Leuk Lymphoma (2014) 0.79
The biology and cytogenetics of multiple myeloma. Rev Clin Exp Hematol (2002) 0.79
Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma. Oncoimmunology (2012) 0.79
Diagnosis of a naturally occurring dual infection of layer chickens with fowlpox virus and gallid herpesvirus 1 (infectious laryngotracheitis virus). Avian Pathol (2010) 0.79
Multiple myeloma: challenges and opportunities. Methods Mol Med (2005) 0.78
Oral cancer: prevention and detection in primary dental healthcare. Prim Dent Care (2002) 0.78
Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998-2006: factors associated with improved survival outcome. Leuk Lymphoma (2011) 0.78
B7+ T cells in myeloma: an acquired marker of prior chronic antigen presentation. Leuk Lymphoma (2004) 0.77
Langerhans cell histiocytosis with refractory central nervous system involvement responsive to infliximab. J Neurol Neurosurg Psychiatry (2011) 0.77
Synthetic nonamer peptides derived from insect defensin mediate the killing of African trypanosomes in axenic culture. Parasitol Res (2009) 0.76
Prediction of high affinity class I-restricted multiple myeloma idiotype peptide epitopes. Leuk Lymphoma (2003) 0.76
Medical professionalism: what does the public think? Clin Med (2010) 0.75
5.1 The demography of oral diseases, future challenges and the implications for dental education. Eur J Dent Educ (2002) 0.75
Raising the standard: changes to the Australian Code of Good Manufacturing Practice (cGMP) for human blood and blood components, human tissues and human cellular therapy products. Pathology (2014) 0.75
Identification of malignant plasma cells by mRNA in situ hybridization. Methods Mol Med (2005) 0.75
Factors influencing the QMF resolution for operation in stability zones 1 and 3. J Am Soc Mass Spectrom (2012) 0.75
Primary cutaneous CD8-positive T-cell lymphoma: a case report of a rare and aggressive disease with oral presentation. Dent Update (2011) 0.75
Rapidly fatal post-allogeneic stem cell transplant lymphoproliferative disorder presenting with skin and bone marrow involvement. Pathology (2013) 0.75
Using an alarm to improve drug trolley safety. Nurs Times (2015) 0.75
Children must be protected from the tobacco industry's marketing tactics. BMJ (2013) 0.75
Southern blotting of IgH rearrangements in B-cell disorders. Methods Mol Med (2005) 0.75